NANOPARTICLE DRUG CONJUGATES
    10.
    发明公开
    NANOPARTICLE DRUG CONJUGATES 审中-公开
    纳米颗粒药物偶联物

    公开(公告)号:EP3148591A1

    公开(公告)日:2017-04-05

    申请号:EP15727248.5

    申请日:2015-05-27

    IPC分类号: A61K47/50 A61K49/00 A61K51/12

    摘要: Described herein are nanoparticle drug conjugates (NDCs), which, in certain embodiments, comprise a non-toxic, multi-modality, clinically proven silica-based nanoparticle platform with covalently attached drug molecules/moieties. The nanoparticle drug conjugates (NDCs) demonstrate imaging capability and targeting ligands which efficiently clear through the kidneys. Furthermore, the conjugates incorporate therapeutic agents for cancer detection, prevention, and/or treatment.

    摘要翻译: 本文描述了纳米颗粒药物缀合物(NDC),其在某些实施方案中包含具有共价连接的药物分子/部分的无毒,多模态,临床证明的基于二氧化硅的纳米颗粒平台。 纳米颗粒药物缀合物(NDCs)展示成像能力和靶向配体,其有效透过肾脏。 此外,缀合物掺入用于癌症检测,预防和/或治疗的治疗剂。